The development of targeted therapy in small cell lung cancer.
about
ADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer.Focused molecular analysis of small cell lung cancer: feasibility in routine clinical practice.Apolipoproteins as Differentiating and Predictive Markers for Assessing Clinical Outcomes in Patients with Small Cell Lung Cancer.An innocent appearing subcutaneous nodule diagnoses a small cell lung cancer in a never-smoker female.Diabetes mellitus increases postoperative mortality in non-small cell lung cancer.Overexpression of MCPH1 inhibits uncontrolled cell growth by promoting cell apoptosis and arresting the cell cycle in S and G2/M phase in lung cancer cells
P2860
The development of targeted therapy in small cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The development of targeted therapy in small cell lung cancer.
@en
The development of targeted therapy in small cell lung cancer.
@nl
type
label
The development of targeted therapy in small cell lung cancer.
@en
The development of targeted therapy in small cell lung cancer.
@nl
prefLabel
The development of targeted therapy in small cell lung cancer.
@en
The development of targeted therapy in small cell lung cancer.
@nl
P2860
P1476
The development of targeted therapy in small cell lung cancer.
@en
P2093
Jianxing He
Yalei Zhang
P2860
P304
P356
10.3978/J.ISSN.2072-1439.2013.07.04
P577
2013-08-01T00:00:00Z